Cargando…

Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy

BACKGROUND: Disorders of calcium and phosphorus metabolism have been reported to be associated with all-cause and cardiovascular mortality in patients requiring long-term dialysis therapy. However, its role in disease progression is not well established in patients without dialysis, especially in im...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Guizhen, Cheng, Jun, Jiang, Yan, Li, Heng, Li, Xiayu, Chen, Jianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406074/
https://www.ncbi.nlm.nih.gov/pubmed/34476094
http://dx.doi.org/10.1093/ckj/sfab002
_version_ 1783746446807269376
author Yu, Guizhen
Cheng, Jun
Jiang, Yan
Li, Heng
Li, Xiayu
Chen, Jianghua
author_facet Yu, Guizhen
Cheng, Jun
Jiang, Yan
Li, Heng
Li, Xiayu
Chen, Jianghua
author_sort Yu, Guizhen
collection PubMed
description BACKGROUND: Disorders of calcium and phosphorus metabolism have been reported to be associated with all-cause and cardiovascular mortality in patients requiring long-term dialysis therapy. However, its role in disease progression is not well established in patients without dialysis, especially in immunoglobulin A (IgA) nephropathy. We aim to evaluate the association of serum phosphorus and calcium and progression of IgA nephropathy. METHODS: We assessed 2567 patients with IgA nephropathy at the First Affiliated Hospital, College of Medicine, Zhejiang University. Serum phosphorus and calcium were collected at the time of kidney biopsy and at each visit. The associations of serum phosphorus and serum calcium with composite kidney disease progression events, defined as 50% estimated glomerular filtration rate (eGFR) decline and kidney failure, were examined using Cox models and restricted cubic splines. RESULTS: During a median follow-up of 31.9 months, 248 (10%) patients reached composite kidney disease progression events. A linear relationship was observed between serum phosphorus and composite kidney disease progression events. With higher levels of phosphorus, the risk of kidney disease progression events increased {hazard ratio [HR] 3.54 [95% confidence interval (CI) 1.37–9.12]; P = 0.009}. Compared with the first quartile group, the HR of kidney disease progression events was 1.66 (95% CI 0.91–301) for the second quartile, 1.67 (95% CI 0.91–3.08) for the third and 2.62 (95% CI 1.44–4.77) for the fourth (P for trend = 0.002). The association between serum phosphorus and kidney disease progression was detectable [HR 8.94 (95% CI 2.33–34.21); P = 0.001] within the subgroup with eGFR <60 mL/min/1.73 m(2) but not among patients with eGFR ≥60 mL/min/1.73 m(2) [HR 0.87 (95% CI 0.17–4.44); P = 0.87]. After adjustment for traditional risk factors, a higher level of serum calcium was not associated with kidney disease progression events [HR 0.33 (95% CI 0.10–1.09)]. CONCLUSIONS: Higher serum phosphorus rather than serum calcium was independently associated with kidney disease progression in IgA nephropathy.
format Online
Article
Text
id pubmed-8406074
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-84060742021-09-01 Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy Yu, Guizhen Cheng, Jun Jiang, Yan Li, Heng Li, Xiayu Chen, Jianghua Clin Kidney J Original Articles BACKGROUND: Disorders of calcium and phosphorus metabolism have been reported to be associated with all-cause and cardiovascular mortality in patients requiring long-term dialysis therapy. However, its role in disease progression is not well established in patients without dialysis, especially in immunoglobulin A (IgA) nephropathy. We aim to evaluate the association of serum phosphorus and calcium and progression of IgA nephropathy. METHODS: We assessed 2567 patients with IgA nephropathy at the First Affiliated Hospital, College of Medicine, Zhejiang University. Serum phosphorus and calcium were collected at the time of kidney biopsy and at each visit. The associations of serum phosphorus and serum calcium with composite kidney disease progression events, defined as 50% estimated glomerular filtration rate (eGFR) decline and kidney failure, were examined using Cox models and restricted cubic splines. RESULTS: During a median follow-up of 31.9 months, 248 (10%) patients reached composite kidney disease progression events. A linear relationship was observed between serum phosphorus and composite kidney disease progression events. With higher levels of phosphorus, the risk of kidney disease progression events increased {hazard ratio [HR] 3.54 [95% confidence interval (CI) 1.37–9.12]; P = 0.009}. Compared with the first quartile group, the HR of kidney disease progression events was 1.66 (95% CI 0.91–301) for the second quartile, 1.67 (95% CI 0.91–3.08) for the third and 2.62 (95% CI 1.44–4.77) for the fourth (P for trend = 0.002). The association between serum phosphorus and kidney disease progression was detectable [HR 8.94 (95% CI 2.33–34.21); P = 0.001] within the subgroup with eGFR <60 mL/min/1.73 m(2) but not among patients with eGFR ≥60 mL/min/1.73 m(2) [HR 0.87 (95% CI 0.17–4.44); P = 0.87]. After adjustment for traditional risk factors, a higher level of serum calcium was not associated with kidney disease progression events [HR 0.33 (95% CI 0.10–1.09)]. CONCLUSIONS: Higher serum phosphorus rather than serum calcium was independently associated with kidney disease progression in IgA nephropathy. Oxford University Press 2021-01-25 /pmc/articles/PMC8406074/ /pubmed/34476094 http://dx.doi.org/10.1093/ckj/sfab002 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Yu, Guizhen
Cheng, Jun
Jiang, Yan
Li, Heng
Li, Xiayu
Chen, Jianghua
Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy
title Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy
title_full Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy
title_fullStr Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy
title_full_unstemmed Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy
title_short Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy
title_sort serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin a nephropathy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406074/
https://www.ncbi.nlm.nih.gov/pubmed/34476094
http://dx.doi.org/10.1093/ckj/sfab002
work_keys_str_mv AT yuguizhen serumphosphorusandcalciumlevelsandkidneydiseaseprogressioninimmunoglobulinanephropathy
AT chengjun serumphosphorusandcalciumlevelsandkidneydiseaseprogressioninimmunoglobulinanephropathy
AT jiangyan serumphosphorusandcalciumlevelsandkidneydiseaseprogressioninimmunoglobulinanephropathy
AT liheng serumphosphorusandcalciumlevelsandkidneydiseaseprogressioninimmunoglobulinanephropathy
AT lixiayu serumphosphorusandcalciumlevelsandkidneydiseaseprogressioninimmunoglobulinanephropathy
AT chenjianghua serumphosphorusandcalciumlevelsandkidneydiseaseprogressioninimmunoglobulinanephropathy